Back to User profile » Dr Yoshinori Watanabe
Papers published by Dr Yoshinori Watanabe:
Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective
Watanabe Y, Yamada S, Otsubo T, Kikuchi T
Drug Design, Development and Therapy 2020, 14:5559-5574
Published Date: 18 December 2020
Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
Watanabe Y, Asami Y, Hirano Y, Kuribayashi K, Itamura R, Imaeda T
Neuropsychiatric Disease and Treatment 2018, 14:1261-1272
Published Date: 16 May 2018
Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
Otsubo T, Watanabe Y, Hongo S, Inoue M, Akimoto K, Murakami K, Takahashi R, Kikuchi T
Neuropsychiatric Disease and Treatment 2018, 14:955-966
Published Date: 6 April 2018
Long-term efficacy and safety of lamotrigine for all types of bipolar disorder
Watanabe Y, Hongo S
Neuropsychiatric Disease and Treatment 2017, 13:843-854
Published Date: 20 March 2017